Global and United States HIV Vaccines Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global HIV Vaccines Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Phase I
  • 1.2.3 Phase II
  • 1.2.4 Phase III
• 1.3 Market by Application
  • 1.3.1 Global HIV Vaccines Market Share by Application: 2020 VS 2026
  • 1.3.2 Research Institute
  • 1.3.3 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global HIV Vaccines Market Perspective (2015-2026)
• 2.2 Global HIV Vaccines Growth Trends by Regions
  • 2.2.1 HIV Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 HIV Vaccines Historic Market Share by Regions (2015-2020)
  • 2.2.3 HIV Vaccines Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top HIV Vaccines Players by Market Size
  • 3.1.1 Global Top HIV Vaccines Players by Revenue (2015-2020)
  • 3.1.2 Global HIV Vaccines Revenue Market Share by Players (2015-2020)
• 3.2 Global HIV Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by HIV Vaccines Revenue
• 3.4 Global HIV Vaccines Market Concentration Ratio
  • 3.4.1 Global HIV Vaccines Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by HIV Vaccines Revenue in 2019
• 3.5 Key Players HIV Vaccines Area Served
• 3.6 Key Players HIV Vaccines Product Solution and Service
• 3.7 Date of Enter into HIV Vaccines Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 HIV Vaccines Breakdown Data by Type (2015-2026)

• 4.1 Global HIV Vaccines Historic Market Size by Type (2015-2020)
• 4.2 Global HIV Vaccines Forecasted Market Size by Type (2021-2026)

5 HIV Vaccines Breakdown Data by Application (2015-2026)

• 5.1 Global HIV Vaccines Historic Market Size by Application (2015-2020)
• 5.2 Global HIV Vaccines Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America HIV Vaccines Market Size (2015-2026)
• 6.2 North America HIV Vaccines Market Size by Type (2015-2020)
• 6.3 North America HIV Vaccines Market Size by Application (2015-2020)
• 6.4 North America HIV Vaccines Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe HIV Vaccines Market Size (2015-2026)
• 7.2 Europe HIV Vaccines Market Size by Type (2015-2020)
• 7.3 Europe HIV Vaccines Market Size by Application (2015-2020)
• 7.4 Europe HIV Vaccines Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China HIV Vaccines Market Size (2015-2026)
• 8.2 China HIV Vaccines Market Size by Type (2015-2020)
• 8.3 China HIV Vaccines Market Size by Application (2015-2020)
• 8.4 China HIV Vaccines Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan HIV Vaccines Market Size (2015-2026)
• 9.2 Japan HIV Vaccines Market Size by Type (2015-2020)
• 9.3 Japan HIV Vaccines Market Size by Application (2015-2020)
• 9.4 Japan HIV Vaccines Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia HIV Vaccines Market Size (2015-2026)
• 10.2 Southeast Asia HIV Vaccines Market Size by Type (2015-2020)
• 10.3 Southeast Asia HIV Vaccines Market Size by Application (2015-2020)
• 10.4 Southeast Asia HIV Vaccines Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Argos Therapeutics
  • 11.1.1 Argos Therapeutics Company Details
  • 11.1.2 Argos Therapeutics Business Overview
  • 11.1.3 Argos Therapeutics HIV Vaccines Introduction
  • 11.1.4 Argos Therapeutics Revenue in HIV Vaccines Business (2015-2020))
  • 11.1.5 Argos Therapeutics Recent Development
• 11.2 Bionor Pharma
  • 11.2.1 Bionor Pharma Company Details
  • 11.2.2 Bionor Pharma Business Overview
  • 11.2.3 Bionor Pharma HIV Vaccines Introduction
  • 11.2.4 Bionor Pharma Revenue in HIV Vaccines Business (2015-2020)
  • 11.2.5 Bionor Pharma Recent Development
• 11.3 Janssen Global Services
  • 11.3.1 Janssen Global Services Company Details
  • 11.3.2 Janssen Global Services Business Overview
  • 11.3.3 Janssen Global Services HIV Vaccines Introduction
  • 11.3.4 Janssen Global Services Revenue in HIV Vaccines Business (2015-2020)
  • 11.3.5 Janssen Global Services Recent Development
• 11.4 Genecure
  • 11.4.1 Genecure Company Details
  • 11.4.2 Genecure Business Overview
  • 11.4.3 Genecure HIV Vaccines Introduction
  • 11.4.4 Genecure Revenue in HIV Vaccines Business (2015-2020)
  • 11.4.5 Genecure Recent Development
• 11.5 Geovax,
  • 11.5.1 Geovax, Company Details
  • 11.5.2 Geovax, Business Overview
  • 11.5.3 Geovax, HIV Vaccines Introduction
  • 11.5.4 Geovax, Revenue in HIV Vaccines Business (2015-2020)
  • 11.5.5 Geovax, Recent Development
• 11.6 Paxvax Corporation
  • 11.6.1 Paxvax Corporation Company Details
  • 11.6.2 Paxvax Corporation Business Overview
  • 11.6.3 Paxvax Corporation HIV Vaccines Introduction
  • 11.6.4 Paxvax Corporation Revenue in HIV Vaccines Business (2015-2020)
  • 11.6.5 Paxvax Corporation Recent Development
• 11.7 Inovio Pharmaceuticals
  • 11.7.1 Inovio Pharmaceuticals Company Details
  • 11.7.2 Inovio Pharmaceuticals Business Overview
  • 11.7.3 Inovio Pharmaceuticals HIV Vaccines Introduction
  • 11.7.4 Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2015-2020)
  • 11.7.5 Inovio Pharmaceuticals Recent Development
• 11.8 Glaxosmithkline
  • 11.8.1 Glaxosmithkline Company Details
  • 11.8.2 Glaxosmithkline Business Overview
  • 11.8.3 Glaxosmithkline HIV Vaccines Introduction
  • 11.8.4 Glaxosmithkline Revenue in HIV Vaccines Business (2015-2020)
  • 11.8.5 Glaxosmithkline Recent Development
• 11.9 Sanofi
  • 11.9.1 Sanofi Company Details
  • 11.9.2 Sanofi Business Overview
  • 11.9.3 Sanofi HIV Vaccines Introduction
  • 11.9.4 Sanofi Revenue in HIV Vaccines Business (2015-2020)
  • 11.9.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer